James H. Heller

1.5k total citations
20 papers, 1.1k citations indexed

About

James H. Heller is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Psychiatry and Mental health. According to data from OpenAlex, James H. Heller has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 7 papers in Genetics and 7 papers in Psychiatry and Mental health. Recurrent topics in James H. Heller's work include Down syndrome and intellectual disability research (10 papers), Genetics and Neurodevelopmental Disorders (6 papers) and Child Nutrition and Feeding Issues (5 papers). James H. Heller is often cited by papers focused on Down syndrome and intellectual disability research (10 papers), Genetics and Neurodevelopmental Disorders (6 papers) and Child Nutrition and Feeding Issues (5 papers). James H. Heller collaborates with scholars based in United States, Switzerland and Japan. James H. Heller's co-authors include Priya S. Kishnani, Robert H. Margolis, Gail A. Spiridigliozzi, Jennifer S. Li, Danny Benjamin, Deeksha Bali, Hanna Mandel, Paula Goldenberg, Dwight D. Koeberl and Stephanie DeArmey and has published in prestigious journals such as Journal of Speech Language and Hearing Research, Molecular Genetics and Metabolism and Dysphagia.

In The Last Decade

James H. Heller

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James H. Heller United States 17 414 259 225 220 182 20 1.1k
Anne Tournay United States 13 195 0.5× 161 0.6× 179 0.8× 75 0.3× 560 3.1× 20 1.1k
Gösta Blennow Sweden 20 147 0.4× 29 0.1× 332 1.5× 60 0.3× 263 1.4× 32 1.1k
Harrison N. Jones United States 19 750 1.8× 21 0.1× 52 0.2× 503 2.3× 301 1.7× 54 1.0k
Erika F. Augustine United States 16 363 0.9× 56 0.2× 109 0.5× 133 0.6× 63 0.3× 69 879
Eray Dırık Türkiye 19 143 0.3× 37 0.1× 119 0.5× 39 0.2× 584 3.2× 72 1.2k
Nathanel Zelnik Israel 19 108 0.3× 35 0.1× 283 1.3× 56 0.3× 673 3.7× 58 1.3k
Abigail L. Gilbert United States 10 309 0.7× 29 0.1× 128 0.6× 233 1.1× 122 0.7× 15 662
Hadassa Goldberg‐Stern Israel 23 152 0.4× 75 0.3× 253 1.1× 69 0.3× 790 4.3× 51 1.6k
Aglaia Vignoli Italy 27 391 0.9× 147 0.6× 490 2.2× 98 0.4× 781 4.3× 116 2.2k
Amy Vierhile United States 14 218 0.5× 35 0.1× 94 0.4× 83 0.4× 56 0.3× 42 461

Countries citing papers authored by James H. Heller

Since Specialization
Citations

This map shows the geographic impact of James H. Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James H. Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James H. Heller more than expected).

Fields of papers citing papers by James H. Heller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James H. Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James H. Heller. The network helps show where James H. Heller may publish in the future.

Co-authorship network of co-authors of James H. Heller

This figure shows the co-authorship network connecting the top 25 collaborators of James H. Heller. A scholar is included among the top collaborators of James H. Heller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James H. Heller. James H. Heller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spiridigliozzi, Gail A., Celia Goeldner, Jamie O. Edgin, et al.. (2018). Adaptive behavior in adolescents and adults with Down syndrome: Results from a 6‐month longitudinal study. American Journal of Medical Genetics Part A. 179(1). 85–93. 5 indexed citations
2.
Spiridigliozzi, Gail A., Sarah J. Hart, James H. Heller, et al.. (2016). Safety and efficacy of rivastigmine in children with Down syndrome: A double blind placebo controlled trial. American Journal of Medical Genetics Part A. 170(6). 1545–1555. 18 indexed citations
3.
D’ardhuy, Xavier Liogier, Jamie O. Edgin, Susana Solá, et al.. (2015). Assessment of Cognitive Scales to Examine Memory, Executive Function and Language in Individuals with Down Syndrome: Implications of a 6-month Observational Study. Frontiers in Behavioral Neuroscience. 9. 300–300. 71 indexed citations
4.
Spiridigliozzi, Gail A., James H. Heller, & Priya S. Kishnani. (2012). Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: Long‐term follow‐up. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 160C(1). 22–29. 22 indexed citations
5.
Spiridigliozzi, Gail A., James H. Heller, Laura E. Case, Harrison N. Jones, & Priya S. Kishnani. (2011). Early cognitive development in children with infantile Pompe disease. Molecular Genetics and Metabolism. 105(3). 428–432. 20 indexed citations
6.
Heller, James H., et al.. (2010). Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: Long-Term Follow-Up. Journal of Child and Adolescent Psychopharmacology. 20(6). 517–520. 16 indexed citations
7.
Kishnani, Priya S., James H. Heller, Gail A. Spiridigliozzi, et al.. (2010). Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10–17. American Journal of Medical Genetics Part A. 152A(12). 3028–3035. 63 indexed citations
8.
Jones, Harrison N., et al.. (2009). Language and speech function in children with infantile Pompe disease. Journal of Pediatric Neurology. 7(2). 147–156. 32 indexed citations
9.
Kishnani, Priya S., Paula Goldenberg, Stephanie DeArmey, et al.. (2009). Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Molecular Genetics and Metabolism. 99(1). 26–33. 285 indexed citations
10.
Jones, Harrison N., Min Lin, Suhrad G. Banugaria, et al.. (2009). Oropharyngeal Dysphagia in Infants and Children with Infantile Pompe Disease. Dysphagia. 25(4). 277–283. 77 indexed citations
11.
Kishnani, Priya S., Barbara Sommer, Benjamin L. Handen, et al.. (2009). The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome. American Journal of Medical Genetics Part A. 149A(8). 1641–1654. 41 indexed citations
12.
Spiridigliozzi, Gail A., James H. Heller, Blythe G. Crissman, et al.. (2007). Preliminary study of the safety and efficacy of donepezil hydrochloride in children with Down syndrome: A clinical report series. American Journal of Medical Genetics Part A. 143A(13). 1408–1413. 31 indexed citations
13.
Heller, James H., Gail A. Spiridigliozzi, Blythe G. Crissman, et al.. (2006). Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: A Preliminary 20-Week, Open-Label Study. Journal of Child and Adolescent Psychopharmacology. 16(6). 755–765. 33 indexed citations
14.
Heller, James H., et al.. (2006). Clinical trials in children with Down syndrome: Issues from a cognitive research perspective. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 142C(3). 187–195. 21 indexed citations
15.
Heller, James H., Gail A. Spiridigliozzi, Jennifer A. Sullivan, et al.. (2002). Donepezil for the treatment of language deficits in adults with Down syndrome: A preliminary 24‐week open trial. American Journal of Medical Genetics Part A. 116A(2). 111–116. 44 indexed citations
16.
Sturner, Raymond, et al.. (1994). Preschool Speech and Language Screening. American Journal of Speech-Language Pathology. 3(1). 25–36. 28 indexed citations
17.
Heller, James H., Raymond Sturner, Sandra G. Funk, & M.D. Feezor. (1993). The Effect of Input Mode on Vocabulary Identification Performance at Low Intensity. Journal of Educational Computing Research. 9(4). 509–518. 3 indexed citations
18.
Sturner, Raymond, James H. Heller, Sandra G. Funk, & Thomas L. Layton. (1993). The Fluharty Preschool Speech and Language Screening Test. Journal of Speech Language and Hearing Research. 36(4). 738–745. 54 indexed citations
19.
Margolis, Robert H. & James H. Heller. (1987). Screening Tympanometry: Criteria for Medical Referral. International Journal of Audiology. 26(4). 197–208. 153 indexed citations
20.
Broen, Patricia A., et al.. (1983). Perception and Production of Approximant Consonants by Normal and Articulation-Delayed Preschool Children. Journal of Speech Language and Hearing Research. 26(4). 601–608. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026